Gabapentin Market Size & Share 2024 to 2032
Market Size by Type (Generic, Branded), Dosage Form (Capsule, Tablet, Oral Solution), Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome), Distribution Channel.
Report ID: GMI6722
|
Published Date: September 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Gabapentin Market Size
Gabapentin Market was estimated to be worth of USD 2.1 billion in 2023 and is estimated to expand at 4.9% CAGR from 2024 to 2032, due to the rising incidence of neuropathic pain, the growing off-label utilization of gabapentin, the broadening spectrum of gabapentin's applications, and the increasing recognition of gabapentin as an efficacious choice for pain management drug.
Gabapentin Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Gabapentin is a medication mainly prescribed to treat specific types of neuropathic pain and as an anticonvulsant. It is a member of the gabapentinoids drug class. It works by impacting certain chemicals in the brain and nerves that are involved in the sensation of pain and seizures.
COVID-19 Impact
During the pandemic, there were concerns about potential supply chain disruptions and availability of essential medications, including gabapentin. These disruptions impacted the timely availability of gabapentin prescriptions for some patients. At the peak of the pandemic, healthcare systems faced significant closure. Elective procedures were delayed, and access to in-person medical appointments was severely restricted for many people who suffer from epilepsy or neuropathic pain. Some patients faced challenges to receive timely care, including medication adjustments. During the pandemic, people experienced increased levels of stress, anxiety, and effects of social isolation. Some people with epilepsy, may experience an increase in seizure frequency due to the stress and anxiety. The pandemic highlighted the importance of mental health.
Gabapentin Market Driving Factors
The rising prevalence of epilepsy worldwide is a significant driver for the industry. Gabapentin is widely used as an antiepileptic drug to treat seizures, and the rising number of people are being diagnosed with epilepsy, contributes to the increasing demand. According to WHO, around 50 million people are affected with epilepsy which makes it the most common neurological disease worldwide. Different forms of neuropathic pain, such as diabetic neuropathy, postherpetic neuralgia (pain after shingles), and peripheral neuropathy can be effectively treated with gabapentin. With the increasing global ageing population incidence of conditions like diabetes is rising, leading to the increasing demand for neuropathic pain management solutions, including gabapentin.
Gabapentin Restraining Factors
The gabapentin market restraining factors such as side effects associated with gabapentin, availability of alternative treatments, and increasing misuse of gabapentin. Certain side effects, including dizziness, drowsiness, and gastrointestinal issues are associated with gabapentin. Additionally, with time few patients may develop tolerance to gabapentin, necessitating higher doses for the same level of effectiveness.
Gabapentin Market Analysis
Based on type, the gabapentin market is classified into generic and branded. In 2022, the generic segment accounted for highest market share of 79.3%. Generic versions of gabapentin are often more widely available, as multiple manufacturers may produce and distribute them. Generally, the generic medications are more affordable than their branded versions. This cost-effectiveness is particularly important for patients and healthcare systems, as it can lead to significant savings in medication expenses. Due to this the generic gabapentin is valuable option, particularly for long-term treatments like epilepsy and chronic pain management.
Based on dosage form, the gabapentin market is classified into capsule, tablet, and oral solution. Among the dosage forms, the capsule segmentis expected to grow at CAGR of 4.9% by 2032. Compared to tablets the capsules offer greater flexibility in terms of dosage adjustments. It allows the healthcare providers to often prescribe specific capsule strengths and alter the dosage as per the requirements. This offers more precise dosing, particularly when patients require doses that fall between standard tablet strengths.
Gabapentin capsules are designed in such a way that the medication is protected from environmental factors such as moisture, light, and air, which can degrade the effectiveness of the drug. Due to the enhanced stability the medication remains potent throughout its shelf life. Owing to the high prescription rate and widespread availability of gabapentin capsules in 100 mg, 300 mg, and 500 mg dosages.
Based on application, the gabapentin market is segmented into epilepsy, neuropathic pain, restless legs syndrome, and other applications. The epilepsy segment is expected to grow at CAGR of 4.7% by 2032. Gabapentin is classified as an anticonvulsant or antiepileptic medication, specifically designed to assist in the control and prevention of seizures. It functions by modulating the activity of certain neurotransmitters and ion channels in the brain, which minimizes the risk of abnormal electrical activity that leads to seizures.
Based on the distribution channel, the gabapentin market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the hospital pharmacies segment held highest market share of 56.2% and is projected to reach USD 1.8 billion. Hospitals serve as primary healthcare facilities where patients receive treatments for a wide range of medical conditions, including the management of chronic ailments such as epilepsy and neuropathic pain. Gabapentin is frequently prescribed for these conditions, and hospitals play a crucial role in ensuring that patients receive their prescribed medications while under their care.
Based on the region, the gabapentin market in North America was valued to be USD 786.3 million in 2022. The rising prevalence of epilepsy, neuropathic pain, increasing applications of gabapentin for different medical conditions, presence of key players in the industry, research and development of products are collectively boosting the growth of this market. In addition to this, widespread availability and accessibility and increased adoption of gabapentin in North America is expected to support the expansion of this industry.
Gabapentin Market Share
The key players in the gabapentin market are :
Gabapentin Industry News:
The gabapentin market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type
By Dosage Form
By Application
By Distribution Channel
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →